Home > Journals > Indian Journal of Communicable Diseases

Indian Journal of Communicable Diseases

Submit your article Read this Journals View all journals
Full Text (PDF)
Original Article

Mucormycosis and Covid: Why in India?

Sudhagar Rengasamy, Senior Resident, Institute of Surgical Gastroenterology & Liver Transplant, Government Stanley Medical College, Chennai, Tamil Nadu 600001, India. , Jeswanth Sathyanesan1 , Sudhagar Rengasamy2 , Murugesan Satish Devakumar3 , Selvaraj Thangasamy4 , Venkatesh NR5 , Kiran Urabinahatti6

Author Information

Licence:



Indian Journal of Communicable Diseases 7(2):p 41-48, July – December 2021. | DOI: http://dx.doi.org/10.21088/ijcd.2395.6631.7221.5

How Cite This Article:

 

Jeswanth Sathyanesan, Sudhagar Rengasamy, Murugesan Satish Devakumar, et al. Mucormycosis and Covid: Why in India?, Indian J Comm Dis. 2021;7(2):41–48.
 

Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Background: CAM (COVID-19 associated invasive Mucormycosis) has been increasingly documented in patients with coronavirus disease 2019 (COVID-19). Predisposing factors include diabetes, steroid use, neutropenia, malignancies, and immunocompromised individuals. The etiology and the exact route of entry for CAM in COVID patients are poorly understood. In India, the incidence of CAM in COVID patients is on the rise. Repeated use of steam inhalation with herbal medicines might cause nasal mucosal trauma which leads to CAM Patients and Methods: Analytical cross-sectional study was conducted to determine the cause for CAM. COVID positive patients with and without Mucormycosis admitted to our hospital were included in the study. A detailed history about the practice of steam inhalation, comorbid illnesses like Diabetes Mellitus (DM), and the use of steroids were assessed and analyzed. Results: 63 CAM patients and 154 Non-Mucormycosis COVID positive patients were taken for the study and analyzed. Injudicious use of steam inhalation (84.1% vs 40.9%) multiple times per day (> 3 times) are strongly associated with CAM among COVID-positive patients (P value 0.0001). Uncontrolled DM (P-value 0.011) and prolonged duration of steroids > 8 days (P-value <0.001) were significantly associated with CAM when compared to control groups. Early diagnosis and treatment improved the outcome of CAM patients. Conclusion: Injudicious use of steam inhalation can cause nasal mucosal trauma which can result in Invasive Mucormycosis in already immune depleted COVID positive patients Keywords: CAM COVID-19 associated invasivemucormycosis); Coronavirus disease 2019 (COVID-19); Steam inhalation.

References

No records found.


About this article

Cite this article

 

Jeswanth Sathyanesan, Sudhagar Rengasamy, Murugesan Satish Devakumar, et al. Mucormycosis and Covid: Why in India?, Indian J Comm Dis. 2021;7(2):41–48.
 

Licence:



Received Accepted Published
N/A N/A N/A
DOI: http://dx.doi.org/10.21088/ijcd.2395.6631.7221.5

Keywords


Article Level Metrics

Last Updated

Sunday 06 September 2026, 00:40:23 (IST)

1117

Accesses

2
231
00

Citations


NA
NA
NA

Download citation


Article Keywords

Keyword Highlighting

Highlight selected keywords in the article text.


Timeline

Received N/A
Accepted N/A
Published N/A

licence




Access this article

Reprint Order Form
Buy this Article
Institutional Subscriptions

Share